During his time at Hologic, Kevin R. Thornal was active in trading company stock. His notable transactions include selling shares worth $1.76 million in November 2019 and continued significant sales leading up to 2023. At one point in 2021, his...

During his time at Hologic, Kevin R. Thornal was active in trading company stock. His notable transactions include selling shares worth $1.76 million in November 2019 and continued significant sales leading up to 2023. At one point in 2021, his sell transactions totaled over $5.98 million in a single month. His trading history indicates a keen awareness of market dynamics and a strong belief in the value of Hologic, as evidenced by his strategic decisions to sell at opportune times. However, by April 2023, his stock holdings had shifted post-resignation, with no outstanding equity awards left. This reshuffling marks a significant change in his financial engagement with the company as he transitioned to a new role as a CEO elsewhere.